4th Quarter - Report

PODESTA GROUP, INC. for COVIDIEN

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Pub. L. 112-29, Leahy-Smith America Invents Act.

LobbyistCovered position, as disclosed
ARANTHAN JONES —
THOMAS B SPARKMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
ARANTHAN JONES —
STEPHEN NORTHRUP —
THOMAS B SPARKMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 99 (112th), H.R. 3206 (112th), H.R. 3211 (112th), H.R. 3207 (112th), H.R. 3214 (112th), H.R. 3205 (112th), H.R. 3204 (112th), H.R. 3230 (112th), S. 1972 (112th), H.R. 3203 (112th), S. 1865 (112th), S. 1700 (112th), S. 1995 (112th), S. 1943 (112th), H.R. 3209 (112th), H.R. 3208 (112th)

Taxation/Internal Revenue Code TAX

International taxation on direct foreign investment.

LobbyistCovered position, as disclosed
CRISTINA ANTELO New —
DANIELE BAIERLEIN —
ARANTHAN JONES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

H.R. 2055, Consolidated Appropriations Act, 2012.

LobbyistCovered position, as disclosed
ARANTHAN JONES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2055 (112th)

Pharmacy PHA

Issues involving controlled substances and pain and addiction drugs. Issues related to acetaminophen.

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
ARANTHAN JONES —
STEPHEN NORTHRUP —
ANTHONY PODESTA —
THOMAS B SPARKMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.